Global Custom Protein Production Services Market Growth (Status and Outlook) 2026-2032

The global Custom Protein Production Services market size is predicted to grow from US$ 1932 million in 2025 to US$ 2807 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.

Custom Protein Production Services are tailored, end-to-end bioprocessing solutions that design, synthesize, express, purify, and validate recombinant proteins according to clients’ unique research, diagnostic, or therapeutic requirements, covering gene optimization, vector construction, host cell expression (microbial, yeast, insect, mammalian), tag removal, endotoxin elimination, formulation, and quality control to deliver proteins with specified purity, activity, scale, and format for non-standard or proprietary targets not available as off-the-shelf products.

Key trends include growing adoption of AI-driven sequence optimization, single-use and automated bioprocessing, and specialized platforms for difficult-to-express and membrane proteins; opportunities are driven by rising outsourcing in biotech/pharma drug discovery, vaccine development, antibody and cell therapy research, and demand for GMP-compliant custom manufacturing; challenges involve high technical complexity, strict regulatory compliance, batch consistency control, high costs for mammalian expression, and technical bottlenecks for complex protein folding and post-translational modifications.

LPI (LP Information)' newest research report, the “Custom Protein Production Services Industry Forecast” looks at past sales and reviews total world Custom Protein Production Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Custom Protein Production Services sales for 2026 through 2032. With Custom Protein Production Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Custom Protein Production Services industry.

This Insight Report provides a comprehensive analysis of the global Custom Protein Production Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Custom Protein Production Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Custom Protein Production Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Custom Protein Production Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Custom Protein Production Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Custom Protein Production Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
Microbial Expression Service
Eukaryotic Expression Service
Others

Segmentation by Service Scope:
Full‑Cycle Custom Service
Expression‑Only Service
Purification‑Only Service

Segmentation by Application:
Biopharmaceutical Drug Discovery
Monoclonal Antibody Development
Vaccine Antigen Production
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Biomatik
R&D Systems
Applied Biological Materials Inc. (abm)
VectorBuilder
BiologicsCorp
Proteos
RayBiotech
Leinco Technologies
Kinexus Bioinformatics
InVivo BioTech Services GmbH
Expression Systems
Creative Biolabs
G&P Biosciences
Eurofins Discovery
Levprot Bioscience
eEnzyme
NorthX Biologics
Jubilant Biosys
GenScript
Boster Bio
Sino Biological
WuXi Biologic
CUSABIO TECHNOLOGY

Please note: The report will take approximately 2 business days to prepare and deliver. Show more